Euronews
Europe · 22 mins ago
AstraZeneca quarterly net profit rises 2% on strong cancer drug sales
Strong cancer drug sales lifted Anglo-Swedish pharmaceutical giant AstraZeneca’s second-quarter earnings above expectations, helping the company maintain its 2026 outlook.
Do you trust Euronews?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!